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Stereotactic Radiosurgery (SRS) is a non-invasive technique for
the delivery of highly focused ionizing radiation with extreme
accuracy. It is used in neurosurgical practice as a less invasive
means of targeting benign and malignant brain tumors.
Its ability to elicit a desired response (e.g. tumor cell death)
with minimal effect on normal surrounding structures is
one of the many benefits that have led to more widespread
use of stereotactic radiosurgical procedures in recent years
under the guidance of a multidisciplinary team comprised of a
neurosurgeon, radiation oncologist and medical physicist. To
achieve the desired outcome, the SRS procedure can be per-
formed in either a single treatment or in several applications
(hypofractionated or conventional fractionated). Stereotactic
radiosurgery is most often an outpatient procedure.
Novel imaging techniques have been developed to optimize
and expand the uses of the stereotactic radiosurgery. Com-
puter tomography (CT) and magnetic resonance imaging (MRI)
techniques have improved the quality of the brain image and
achieved a more precise localization of tumors in the brain.
Combining these innovative imaging technologies with high-
speed workstations that rapidly calculate and display 3-D dose
distributions enables more effective and productive uses of
these technologies. In addition, positron emission tomogra-
phy (PET) scans provide images that include metabolic data
and functional data and in doing so add another layer of
sophistication in the treatment of more complex targets such
as rapidly proliferating tumors, including gliomas and metas-
tases.
Radiosurgery is an especially attractive therapeutic option
for brain metastases (the most common adult brain tumor)
because it can be used to treat small lesions that would
be otherwise inaccessible with invasive surgery due to sen-
sitive adjacent critical structures. Stereotactic radiosurgery
is currently being used to treat newly diagnosed metastatic
tumors, recurrent brain metastases after previous whole
brain radiation therapy (WBRT), and as a “boost” after WBRT.
Metastatic brain tumors have high incidence and follow a
rapidly progressive course, requiring complex management
which includes a combination of surgery, radiation and radio-
surgery.
Solitary metastases are especially good targets for radio-
surgical treatment when they are caught in earlier stages by
MRI surveillance at less than 3.5 cm, because they are usu-
ally spherical, discrete and contrast enhancing, allowing for
accurate lesion delineation. In addition, most metastases are
uniformly sensitive to single fraction radiotherapy.
For multiple brain metastases, treatment becomes less
effective as the number of tumors increases. A study demon-
strated that the probability of tumor control after surgery and
WBRT or radiosurgery decreases from 64% for one intracra-
nial metastasis, to 51% for two tumors, and to 41% for three.
Patients with fewer than four small- or medium-sized tumors
can respond favorably to stereotactic radiosurgery. Hypofrac-
tionated radiosurgery is the preferred option for patients
that are poor surgical candidates due to co-morbidities or
advanced systemic disease and it can be combined with
resection for treatment of larger tumors. FSRT can particularly
be beneficial for patients with large lesions or lesions located
near critical structures.
In general, algorithms are followed to treat brain metas-
tases through multimodal techniques that combine resection,
WBRT and radiosurgery in attempt to maximize survival rates.
SRS was also used in the management of gliomas. Gliomas
have astrocytic, oligodendroglial, ependymal and mixed sub-
types. Low grade gliomas (LGG) are curable by means of
current multimodal treatment techniques, the main goal in
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high grade gliomas (HGG) is the prolongation of survival with
a high quality of life as much as possible. Currently, there
are many ongoing clinical studies focused on the role of SRS
in the management of gliomas. In most cases, the treat-
ment protocols should be individualized. SRS seems a valuable
treatment option for local control of recurrent or residual
ependymomas. Although the guideline indications of SRS in
the management of gliomas are not definite yet, favorable
results are being reported especially for pilocytic astrocytoma
and ependymoma. SRS also makes significant contributions
to multimodal treatment modality of GBM as an adjuvant, as
well. SRS might safely be used for carefully selected patients
with low complication rates and high efficacy. Many pru-
dential studies are also conducted in this growing field of
neurosurgery.
It presents an especially attractive alternative option to
invasive surgery for patients with co-morbidities. Radio-
surgery continues to be constantly evaluated for its benefits,
risks, and effectiveness in comparison to standard surgical,
radiation and pharmacological options.
